Target intelligence / Profile preview

Schistosoma tegument

Molecular classification
Other
01

Overview

The Schistosoma tegument is a complex, syncytial cytoplasmic layer that forms the outer surface of the adult blood fluke, serving as the vital interface between the parasite and its human host (Skelly & Wilson, 2006). It performs multiple essential biological functions, including the absorption of nutrients such as glucose and amino acids, the regulation of osmotic balance, and the execution of sophisticated immune evasion strategies like molecular mimicry and rapid membrane turnover (Braschi et al., 2006). Structurally, it is unique for its double-lipid bilayer, or heptalaminar membrane, which protects the worm from the host's proteolytic enzymes and immune effectors. The tegument is the primary site of action for praziquantel, the standard treatment for schistosomiasis, which causes immediate tegumental damage and exposes the parasite to host immune attack (Doenhoff et al., 2008). Because it is directly exposed to the host's blood and contains numerous essential proteins, the tegument is a high-priority target for the development of new drugs and vaccines aimed at controlling schistosomiasis (CDC, 2022).

Other names
Schistosome tegumentTegumental structuresSyncytial tegumentSchistosome surface
02

Mechanism of action

Anthelmintic drugs like praziquantel disrupt the tegumental integrity by inducing a rapid influx of calcium ions, which leads to severe vacuolization, surface blebbing, and muscle contraction (Doenhoff et al., 2008). This damage exposes sequestered parasite antigens to the host's immune system, facilitating the recruitment of leucocytes and subsequent parasite clearance (Skelly & Wilson, 2006).

03

Biological functions

Nutrient absorptionImmune evasionOsmoregulationSignal transductionProtection
04

Disease associations

Infection
05

Safety considerations

Development of drug resistanceReduced efficacy against immature schistosomulaHost inflammatory response to released parasite antigens
06

Interacting drugs

Praziquantel

4 more in the full profile.

07

Biomarkers

Circulating anodic antigen (CAA)Circulating cathodic antigen (CCA)

Beyond the preview

Go deeper on Schistosoma tegument.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schistosoma tegument.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call